IIM
INTECH Investment Management Portfolio holdings
AUM
$10.7B
1-Year Return
23.47%
This Quarter Return
-4.73%
1 Year Return
+23.47%
3 Year Return
+97.82%
5 Year Return
–
10 Year Return
–
AUM
$9.7B
AUM Growth
-$615M
(-6%)
Cap. Flow
-$69.8M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
23.8%
Holding
2,583
New
206
Increased
1,731
Reduced
552
Closed
62
Top Buys
| 1 |
Amazon
AMZN
|
$60.1M |
| 2 |
Merck
MRK
|
$56.4M |
| 3 |
SMDX
Intech S&P Small-Mid Cap Diversified Alpha ETF
SMDX
|
$53.5M |
| 4 |
Tesla
TSLA
|
$40.1M |
| 5 |
Broadcom
AVGO
|
$39.1M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$50.3M |
| 2 |
Progressive
PGR
|
$49.8M |
| 3 |
Cintas
CTAS
|
$41.3M |
| 4 |
UnitedHealth
UNH
|
$36.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$35.2M |
Sector Composition
| 1 | Technology | 25.41% |
| 2 | Financials | 14.35% |
| 3 | Healthcare | 12.97% |
| 4 | Consumer Discretionary | 10.79% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2476
HilleVax
HLVX
$105M
| $31.5K | ﹤0.01% |
21,756
+9,109
| +72% | +$13.2K |
|
2477
Pyxis Oncology
PYXS
$118M
| $31.5K | ﹤0.01% |
32,173
+9,682
| +43% | +$9.49K |
|
2478
Acumen Pharmaceuticals
ABOS
$87.2M
| $31.4K | ﹤0.01% |
28,540
+9,693
| +51% | +$10.7K |
|
2479
Mersana Therapeutics
MRSN
$34M
| $31.1K | ﹤0.01% |
3,614
+1,573
| +77% | +$13.5K |
|
|
TPIC
2480
DELISTED
TPI Composites
TPIC
| $30.5K | ﹤0.01% |
37,879
+15,405
| +69% | +$12.4K |
|
2481
Inovio Pharmaceuticals
INO
$148M
| $30.1K | ﹤0.01% |
18,441
+6,434
| +54% | +$10.5K |
|
2482
Fractyl Health
GUTS
$65.4M
| $29.9K | ﹤0.01% |
25,154
+8,740
| +53% | +$10.4K |
|
2483
Purple Innovation
PRPL
$122M
| $29.7K | ﹤0.01% |
+39,081
| New | +$29.7K |
|
2484
Skye Bioscience
SKYE
$124M
| $29.1K | ﹤0.01% |
+18,278
| New | +$29.1K |
|
2485
Applied Therapeutics
APLT
$68.2M
| $28.1K | ﹤0.01% |
57,524
+4,893
| +9% | +$2.39K |
|
2486
Zynex
ZYXI
$45.1M
| $27.6K | ﹤0.01% |
+12,562
| New | +$27.6K |
|
2487
Golden Matrix Group
GMGI
$142M
| $27.2K | ﹤0.01% |
+13,804
| New | +$27.2K |
|
2488
Shattuck Labs
STTK
$74.2M
| $27.2K | ﹤0.01% |
28,599
+10,587
| +59% | +$10.1K |
|
|
CLYM
2489
Climb Bio, Inc. Common Stock
CLYM
$162M
| $25.6K | ﹤0.01% |
21,022
+7,321
| +53% | +$8.93K |
|
2490
Tenaya Therapeutics
TNYA
$220M
| $25.6K | ﹤0.01% |
44,960
+17,032
| +61% | +$9.71K |
|
|
AKYA
2491
DELISTED
Akoya BioSciences
AKYA
| $25.4K | ﹤0.01% |
18,262
+6,482
| +55% | +$9.01K |
|
2492
Roadzen
RDZN
$74.3M
| $24.9K | ﹤0.01% |
+23,941
| New | +$24.9K |
|
2493
PepGen
PEPG
$45.9M
| $24.8K | ﹤0.01% |
+17,626
| New | +$24.8K |
|
2494
Renovaro
RENB
$47.7M
| $24.4K | ﹤0.01% |
+44,878
| New | +$24.4K |
|
2495
LanzaTech
LNZA
$44.5M
| $24.3K | ﹤0.01% |
1,005
+451
| +81% | +$10.9K |
|
2496
Lineage Cell Therapeutics
LCTX
$279M
| $23K | ﹤0.01% |
+50,922
| New | +$23K |
|
2497
Cibus
CBUS
$67.3M
| $22.3K | ﹤0.01% |
+11,910
| New | +$22.3K |
|
2498
Werewolf Therapeutics
HOWL
$61.7M
| $21.6K | ﹤0.01% |
22,239
+7,373
| +50% | +$7.17K |
|
2499
Acrivon Therapeutics
ACRV
$41.8M
| $20.5K | ﹤0.01% |
+10,091
| New | +$20.5K |
|
2500
Harvard Bioscience
HBIO
$21.3M
| $20.3K | ﹤0.01% |
35,911
+19,114
| +114% | +$10.8K |
|